首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Ipilimumab/nivolumabColitis and skin toxicity: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2018年
/ 1696卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-018-44401-9
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:213 / 213
相关论文
共 50 条
[41]
NivolumabColitis: case report
Reactions Weekly,
2022,
1926
(1)
: 373
-
373
[42]
Ipilimumab/nivolumabHepatic toxicity: case report
Reactions Weekly,
2022,
1887
(1)
: 395
-
395
[43]
Ipilimumab/nivolumabHepatic toxicity: case report
Reactions Weekly,
2022,
1908
(1)
: 303
-
303
[44]
NivolumabColitis: case report
Reactions Weekly,
2017,
1665
(1)
: 213
-
213
[45]
Ipilimumab/nivolumabVogt-Koyanagi-Harada disease, duodenitis and skin toxicity: case report
Reactions Weekly,
2019,
1747
(1)
: 161
-
161
[46]
NivolumabColitis and pancreatitis: case report
Reactions Weekly,
2022,
1913
(1)
: 353
-
353
[47]
NivolumabColitis and diarrhoea: case report
Reactions Weekly,
2022,
1932
(1)
: 473
-
473
[48]
Ipilimumab/nivolumabLichenoid skin eruption : case report
Reactions Weekly,
2023,
1963
(1)
: 301
-
301
[49]
Ipilimumab/nivolumab/nivolumabColitis and lack of efficacy
Reactions Weekly,
2024,
2005
(1)
: 469
-
469
[50]
NivolumabColitis and liver toxicity: 2 case reports
Reactions Weekly,
2020,
1818
(1)
: 212
-
212
←
1
2
3
4
5
→